Evaluation of the Effects of LUNII on Pre-operative Anxiety and on the Post-operative Period in Children With Cleft Lip and Palate Admitted for Alveolar Bone Graft: Pilot Study

Sponsor
Assistance Publique - Hôpitaux de Paris (Other)
Overall Status
Terminated
CT.gov ID
NCT03740841
Collaborator
(none)
15
1
2

Study Details

Study Description

Brief Summary

The literature on the effects of various devices on per-operative anxiety is scarce. There is currently no study on the effects of an interactive storyteller on per-operative anxiety in pediatric surgery.

The interactive story teller LUNII (available over the counter in France) would reduce pre-operative anxiety, with post-operative effects on pain and hospitalization time.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Interactive story teller LUNII
N/A

Detailed Description

The literature on the effects of various devices on per-operative anxiety is scarce. There is currently no study on the effects of an interactive storyteller on per-operative anxiety in pediatric surgery.

The interactive story teller LUNII (available over the counter in France) would reduce pre-operative anxiety, with post-operative effects on pain and hospitalization time.

Patients admitted for an alveolar bone graft with an iliac donor site as part of the treatment of their cleft lip and palate will be include for two reasons:

  1. It is a homogeneous population - same condition, same treatment, same age at surgery, standardized procedure;

  2. It is a population with long individual medical histories and, potentially, subjected to significant surgery-related stress.

Patients will be randomized into two groups: with LUNII and without LUNII.

In the LUNII group, the interactive story teller LUNII will be delivered the day before surgery during the pre-operative medical visit.

Study Design

Study Type:
Interventional
Actual Enrollment :
15 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Evaluation of the Effects of LUNII on Pre-operative Anxiety and on the Post-operative Period in Children With Cleft Lip and Palate Admitted for Alveolar Bone Graft: Pilot Study
Actual Study Start Date :
Jan 8, 2019
Actual Primary Completion Date :
Jan 8, 2019
Actual Study Completion Date :
Jan 8, 2019

Arms and Interventions

Arm Intervention/Treatment
Other: LUNII

The interactive story teller LUNII is delivered to the child the day before surgery, during the usual pre-operative medical visit.

Behavioral: Interactive story teller LUNII
Use of the interactive story teller LUNII by the child from the pre-operative visit to the discharge.

No Intervention: Without LUNII

Usual pre-operative visit.

Outcome Measures

Primary Outcome Measures

  1. Yale Preoperative Anxiety Scale (mYPAS ) [At the entrance into the operating room]

    Questionnaire, completed in the operating room by an independent observer preferably without knowledge about the child, made of 22 items divided into 5 categories. The score ranges from 5 (minimum anxiety) to 20 (maximum anxiety)

  2. Yale Preoperative Anxiety Scale (mYPAS ) [At the time of anesthetic induction]

    Questionnaire, completed in the operating room by an independent observer preferably without knowledge about the child, made of 22 items divided into 5 categories. The score ranges from 5 (minimum anxiety) to 20 (maximum anxiety)

  3. Number of hours spent with the interactive story teller LUNII before surgery [Day of surgery (D0)]

    Number of hours spent with the interactive story teller LUNII

Secondary Outcome Measures

  1. Analgesic administration [Up to 1 week]

    Evaluation of analgesic administration after surgery during hospital stay

  2. Visual Analogue pain Scale (EVA) [Up to 1 week]

    Self-assessment of pain by a graduated ruler of 0 (no pain) at 100 millimeters (maximum pain imaginable), twice a day during hospitalization

  3. Duration between the operation and the first survey [Up to 1 week]

    Duration between the operation and the first survey

  4. Length of hospitalization [Up to 1 week]

    Length of hospitalization

Eligibility Criteria

Criteria

Ages Eligible for Study:
4 Years to 6 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Children aged 4 to 6 years.

  • Alveolar bone graft with iliac crest donor site in children with unilateral or bilateral cleft lip and palate

  • Primary alveolar bone graft or first side when bilateral cleft

  • Followed at Necker since birth and operated according to the protocol used in the department.

  • Consent signed by the holder (or holders) of parental authority

Exclusion Criteria:
  • Medical care different from the usual protocol applied in the service (secondary surgery, age > 7 years)

  • Known psychomotor delay, associated rare syndrome or disease, known psychiatric disorders, other surgical procedures between hard palate closure and alveolar bone graft

  • Possession and/or prior use of LUNII by the child

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hôpital Necker-Enfants Malades Paris France 75015

Sponsors and Collaborators

  • Assistance Publique - Hôpitaux de Paris

Investigators

  • Principal Investigator: Roman Hossein Khonsari, MD, PhD, Assistance Publique - Hôpitaux de Paris

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT03740841
Other Study ID Numbers:
  • K180306J
  • 2018-A00758-47
First Posted:
Nov 14, 2018
Last Update Posted:
Apr 1, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Assistance Publique - Hôpitaux de Paris
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 1, 2022